Raul Alarcon Jr., CEO of Spanish Broadcasting System Inc., will be honored at the annual American Cancer Society gala as the 2012 Gala Honoree on April 21 at the InterContinental Miami.
Alarcon joined SBS in 1983 as an account executive. He has been the president and director since October 1985 and CEO since June 1994. In November 1999, Alarcon became the chairman of the board of directors and continues as the CEO and president.
Alarcon is responsible for long-range strategic planning and operational matters, and is instrumental in the acquisition and related financing of each of the company's stations.
Alarcon is the son of Pablo Raul Alarcon Sr.
"To be recognized by the American Cancer Society is an honor which I would like to share with the millions of Hispanic entrepreneurs in America who are transforming our economy," Alarcon said. "I am grateful and proud to represent the interests of the growing Hispanic business community around the nation."
SBS owns and operates 21 Spanish-language radio stations in the top Latin markets in the United States. Alarcon has continued to expand the company's reach with the growth of SBS Entertainment and MegaTV, according to the release.
The award highlights Alarcon's strategic vision of integrating radio, television, entertainment and online properties to seek out growth opportunities with the U.S. Hispanic consumer.
More than 700 influential leaders of Miami's social and corporate communities are expected for a night of elegance, exquisite food, and live entertainment. Chairpersons for this year's black-tie fundraiser are Lourdes and Felipe Valls of Valls Group and co-chairs are Madeleine and Pedro Munilla of MCM Corp. Marile and Jorge Luis Lopez of Jorge Luis Lopez Law Firm will serve as honorary co-chairs. This year's presenting sponsor is Florida Healthcare Plus.
The American Cancer Society is a nationwide, community-based voluntary health organization dedicated to eliminating cancer as a major health problem by preventing cancer, saving lives and diminishing suffering from cancer, through research, education, advocacy, and service.
